IL10 and metabolic dysfunction-associated steatotic liver disease: This is also confirmed by the results of inflammatory cytokine IL-10+ [% of CD4+] in the early MASLD group compared to the control group [1.73 (1.45-2.84) vs 1.09 (0.97-1.31), p=0.020] (Table 2).